Gene-Edited cell therapy for lung cancer trial pulled before start
Disease control
Terminated
This trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. It used a patient's own immune cells (TILs) that were edited with CRISPR to remove a gene called CISH, potentially making them better at fighting cancer. The study was withdrawn before…
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC